Handelsbanken Fonder’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Handelsbanken Fonder's ATRC Position: Q2 2026 in Review
Handelsbanken Fonder increased its AtriCure (ATRC) stake by 12% in Q2 2026, buying an estimated $70.3K and bringing the position to 22,800 shares worth $638K. The position accounts for ﹤0.01% of the portfolio, ranked #1302.
Handelsbanken Fonder first reported a position in ATRC in Q1 2021 and has held it in 22 quarters since. The position peaked at $803K in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Handelsbanken Fonder held 22,800 shares of AtriCure worth $638K as of Q2 2026.
- Handelsbanken Fonder bought 2,500 AtriCure shares in Q2 2026, an estimated $70.3K.
- AtriCure made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1302 holding.
- Handelsbanken Fonder first reported a position in AtriCure in Q1 2021 and has held it in 22 quarters since.
- Handelsbanken Fonder's AtriCure position peaked at $803K in Q4 2025.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.